1. Home
  2. CENTA vs NAMS Comparison

CENTA vs NAMS Comparison

Compare CENTA & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CENTA
  • NAMS
  • Stock Information
  • Founded
  • CENTA 1955
  • NAMS 2019
  • Country
  • CENTA United States
  • NAMS Netherlands
  • Employees
  • CENTA N/A
  • NAMS N/A
  • Industry
  • CENTA Consumer Specialties
  • NAMS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CENTA Consumer Discretionary
  • NAMS Health Care
  • Exchange
  • CENTA Nasdaq
  • NAMS Nasdaq
  • Market Cap
  • CENTA 2.2B
  • NAMS 2.3B
  • IPO Year
  • CENTA 1993
  • NAMS N/A
  • Fundamental
  • Price
  • CENTA $32.89
  • NAMS $20.12
  • Analyst Decision
  • CENTA Strong Buy
  • NAMS Strong Buy
  • Analyst Count
  • CENTA 4
  • NAMS 6
  • Target Price
  • CENTA $42.50
  • NAMS $33.80
  • AVG Volume (30 Days)
  • CENTA 264.9K
  • NAMS 634.7K
  • Earning Date
  • CENTA 11-26-2024
  • NAMS 11-06-2024
  • Dividend Yield
  • CENTA N/A
  • NAMS N/A
  • EPS Growth
  • CENTA 42.23
  • NAMS N/A
  • EPS
  • CENTA 2.71
  • NAMS N/A
  • Revenue
  • CENTA $3,281,118,000.00
  • NAMS $33,594,000.00
  • Revenue This Year
  • CENTA N/A
  • NAMS N/A
  • Revenue Next Year
  • CENTA $1.72
  • NAMS N/A
  • P/E Ratio
  • CENTA $12.12
  • NAMS N/A
  • Revenue Growth
  • CENTA 0.42
  • NAMS 78.77
  • 52 Week Low
  • CENTA $27.70
  • NAMS $8.90
  • 52 Week High
  • CENTA $41.03
  • NAMS $26.35
  • Technical
  • Relative Strength Index (RSI)
  • CENTA 64.82
  • NAMS 44.60
  • Support Level
  • CENTA $30.98
  • NAMS $19.59
  • Resistance Level
  • CENTA $32.12
  • NAMS $25.32
  • Average True Range (ATR)
  • CENTA 0.88
  • NAMS 1.44
  • MACD
  • CENTA 0.16
  • NAMS -0.32
  • Stochastic Oscillator
  • CENTA 88.00
  • NAMS 36.35

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: